These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8736339)

  • 1. Successful treatment of bullous pemphigoid with pulsed intravenous cyclophosphamide.
    Itoh T; Hosokawa H; Shirai Y; Horio T
    Br J Dermatol; 1996 May; 134(5):931-3. PubMed ID: 8736339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J; Eaglstein WH
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe bullous pemphigoid responsive to pulsed intravenous dexamethasone and oral cyclophosphamide.
    Dawe RS; Naidoo DK; Ferguson J
    Br J Dermatol; 1997 Nov; 137(5):826-7. PubMed ID: 9415254
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe bullous pemphigoid in an infant--successful treatment with rituximab.
    Schulze J; Bader P; Henke U; Rose MA; Zielen S
    Pediatr Dermatol; 2008; 25(4):462-5. PubMed ID: 18789089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous pemphigoid treatment review.
    Patton T; Korman NJ
    Expert Opin Pharmacother; 2006 Dec; 7(17):2403-11. PubMed ID: 17109614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidural abscess as a side effect of an immunosuppressive therapy treatment for bullous pemphigoid.
    Watabe D; Takahashi K; Tagami H; Akasaka T
    J Dermatol; 2006 Feb; 33(2):153-5. PubMed ID: 16556289
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.
    Mabrouk D; Gürcan HM; Keskin DB; Christen WG; Ahmed AR
    Ann Pharmacother; 2010 Nov; 44(11):1770-6. PubMed ID: 20923942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bullous pemphigoid with low-dose oral cyclophosphamide: a case series of 20 patients.
    Gual A; Iranzo P; Mascaró JM
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):814-8. PubMed ID: 23581830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid.
    Chu J; Bradley M; Marinkovich MP
    Arch Dermatol; 2003 Jun; 139(6):813-5. PubMed ID: 12810523
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
    Kjellman P; Eriksson H; Berg P
    Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immune globulin in the treatment of persistent pemphigoid gestationis.
    Kreuter A; Harati A; Breuckmann F; Appelhans C; Altmeyer P
    J Am Acad Dermatol; 2004 Dec; 51(6):1027-8. PubMed ID: 15583609
    [No Abstract]   [Full Text] [Related]  

  • 13. Bullous scabies failing to respond to glucocorticoids, immunoglobulin, and cyclophosphamide.
    Chen MC; Luo DQ
    Int J Dermatol; 2014 Apr; 53(4):e265-6. PubMed ID: 24134198
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recurrent bleeding tendency due to factor VIII inhibitor during therapy for bullous pemphigoid].
    Kuboki T; Kudo T; Iwata N; Morimoto I
    Rinsho Ketsueki; 1999 Oct; 40(10):1087-92. PubMed ID: 10565226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriatic erythroderma and bullous pemphigoid treated successfully with acitretin and azathioprine.
    Roeder C; Driesch PV
    Eur J Dermatol; 1999; 9(7):537-9. PubMed ID: 10523731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
    Czernik A; Bystryn JC
    Arch Dermatol; 2008 May; 144(5):658-61. PubMed ID: 18490594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy.
    Sugawara N; Nagai Y; Matsushima Y; Aoyama K; Ishikawa O
    J Am Acad Dermatol; 2007 Dec; 57(6):1084-9. PubMed ID: 17889964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.
    Yamauchi PS; Lowe NJ; Gindi V
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S121-2. PubMed ID: 16488323
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical tacrolimus treatment for localized pretibial bullous phemphigoid.
    Calcaterra R; Carducci M; Franco G; Mussi A; Morrone A
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):177-9. PubMed ID: 18410329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.